Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.8B | 6.4B | 6.3B | 6.2B |
Cost of revenue | 4.1B | 4.6B | 4.4B | 4.2B |
Gross profit | 1.7B | 1.7B | 1.9B | 1.9B |
Operating expense | ||||
Research & development | 259.4M | 264.2M | 238.9M | 237.6M |
Selling general and admin | 1.1B | 1.2B | 1.0B | 1.1B |
Other operating expenses | — | — | — | — |
Operating income | 418.8M | 318.2M | 684.5M | 655.8M |
Non operating interest income | ||||
Income | 14.8M | 28.0M | 17.1M | 30.7M |
Expense | 48.3M | 47.8M | 45.1M | 43.7M |
Other income expense | — | — | — | — |
Pretax income | 600.0M | 284.7M | 790.1M | 691.4M |
Tax provision | 142.1M | -18.1M | 148.7M | 133.7M |
Net income | 457.9M | 302.8M | 641.4M | 557.6M |
Basic EPS | 1.4 | — | 1.9 | 1.7 |
Diluted EPS | 1.4 | — | 1.9 | 1.6 |
Basic average shares | 353.8M | — | 353.5M | 352.8M |
Diluted average shares | 354.2M | — | 355.3M | 354.9M |
EBITDA | 1.3B | 928.5M | 1.4B | 1.3B |
Net income from continuing op. | 600.0M | 284.7M | 790.1M | 691.4M |
Minority interests | 24.9M | 27.3M | 23.1M | 24.5M |
Preferred stock dividends | 0 | 0 | 0 | 0 |